QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Achieves Exciting Capital Markets Milestone as It Hits the Russell Index

Trxade Group (NASDAQ: MEDS), an integrated drug and healthcare platform, was recently added to the Russell Microcap Index, which helps raise its profile among investors, furthering its reach to generate long-term shareholder value while limiting marketing expenses. A recent article quotes Trxade Chairman and CEO Suren Ajjarapu about the Russell listing, stating, “This marks an exciting capital markets milestone in the growth and trajectory of our company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community.”

To view the full article, visit http://ibn.fm/iFvtu

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS